<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02530385</url>
  </required_header>
  <id_info>
    <org_study_id>2015-P001632</org_study_id>
    <nct_id>NCT02530385</nct_id>
  </id_info>
  <brief_title>Fecal Microbiota Transplant for Obesity and Metabolism</brief_title>
  <official_title>Placebo Controlled Study of Fecal Microbiota Transplant (FMT) to Impact Body Weight and Glycemic Control in Adults Using a Frozen Encapsulated Inoculum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the impact of gut bacteria on weight. Fecal microbiota
      transplantation (FMT) transfers intestinal bacteria by a &quot;stool transplant&quot; from a healthy,
      lean person to a person with obesity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple lines of evidence suggest that gut microbiota play an important role in regulating
      human metabolism. In this study, subjects will receive FMT capsules from lean metabolically
      healthy donors to study effects on body weight and insulin sensitivity. Subjects who
      participate will be randomized 1:1 to receive either active FMT capsules or placebo capsules.
      Subjects and providers will be blinded to treatment assignment. The study will last for 24
      weeks. Subjects will be asked to come to MGH for a baseline visit at week 0, return for 6
      weekly visits and come back at week 12. Major study outcomes include change in weight,
      insulin sensitivity, and body composition. Fecal samples will also be collected for
      intestinal microbiome analysis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2016</start_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin Resistance (HOMA-IR and hyperinsulinemic euglycemic clamp)</measure>
    <time_frame>6 weeks</time_frame>
    <description>Change in insulin sensitivity from baseline to 6 weeks will be measured via HOMA-IR and by hyperinsulinemic euglycemic clamp.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight (metabolic scale)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Change in body weight from baseline to 12 weeks will be measured on a metabolic scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition (DXA)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Changes in lean and fat mass from baseline to 12 weeks will be measured via dual-energy x-ray absorptiometry</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>FMT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active FMT capsules</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo capsules</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo Capsules</intervention_name>
    <description>Placebo capsules contain powdered cocoa and gelatin</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>FMT Capsules</intervention_name>
    <description>Capsules will be generated as per FDA-approved procedures</description>
    <arm_group_label>FMT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI â‰¥30 kg/m2

          -  Because of frequent study mandated visits, only subjects living within reasonable
             driving distance of Massachusetts General Hospital may be enrolled

        Exclusion Criteria:

          -  Pregnant women

          -  Use of diabetic medications or weight loss medications in the preceding 1 year

          -  Significant gastrointestinal disorders

          -  Significant food allergies

          -  Immunosuppressed patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Petr Stastka, BS</last_name>
    <phone>617-643-7951</phone>
    <email>pstastka@partners.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jasmin Mahabamunuge, BA</last_name>
    <phone>617-724-8625</phone>
    <email>jmahabamunuge@partners.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petr Stastka, BS</last_name>
      <email>pstastka@partners.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 19, 2015</study_first_submitted>
  <study_first_submitted_qc>August 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 21, 2015</study_first_posted>
  <last_update_submitted>May 19, 2017</last_update_submitted>
  <last_update_submitted_qc>May 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Elaine W. Yu</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

